ScholarIQanswers from OpenAlex

Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients

PaperCitations, authors & open-access status

Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients have?

ScholarIQcitation count

Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients has 571 citations in the OpenAlex counts ScholarIQ stores.

When was Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients published?

ScholarIQyear

Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients has 2011 year in the ScholarIQ index.

What is the open-access status of Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients?

ScholarIQoa status

Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients has closed oa status in the ScholarIQ index.

What is the DOI of Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients?

ScholarIQdoi

The DOI for Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients is on the source record.

What is the PMID of Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients?

ScholarIQpmid

The PMID for Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients is on the source record.

What is the OpenAlex record for Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients?

ScholarIQopenalex

The OpenAlex for Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial